2025 LIPEDEMA WORLD CONGRESS
  • HOME
    • CONGRESS PRESIDENTS
    • SCIENTIFIC COMMITTEE
  • PLAN YOUR TRIP
    • GENERAL INFORMATION
    • ABOUT ROME
    • YOUR TRIP IN ROME
    • ACCOMMODATION
  • PRELIMINARY PROGRAM
    • MAIN TOPICS
  • ABSTRACT
  • SPONSORS
  • CONTACTS
  • Basic Science
    Exploration of the fundamental biological and molecular mechanisms underlying lipedema, including adipocyte dysfunction, inflammatory pathways, and extracellular matrix alterations.

  • Epidemiology of Lipedema
    Analysis of the global prevalence and incidence of lipedema, with a focus on genetic predisposition, environmental influences, and ethnic variations in disease manifestation.

  • Pathophysiology
    Investigation of the mechanisms leading to the pathological expansion of subcutaneous fat, chronic inflammation, and progressive fibrosis, as well as the role of hormonal and vascular factors.

  • Metabolic Aspects
    Examination of metabolic dysregulations associated with lipedema, including lipid metabolism, mitochondrial function, and systemic metabolic impairments.

  • Lipedema and Pain
    Understanding the pathogenesis of pain in lipedema, including neuroinflammatory mechanisms, sensory nerve involvement, and the impact on quality of life.

  • Lipedema and Insulin Resistance
    Evaluation of the association between lipedema and insulin resistance, its implications for metabolic syndrome, and potential therapeutic interventions.

  • Lipedema and Obesity
    Differentiation between lipedema and obesity, including diagnostic criteria, metabolic differences, and shared pathophysiological features.

  • Clinical Diagnosis
    Standardized clinical criteria for diagnosing lipedema, emphasizing differential diagnosis and early detection strategies.

  • Instrumental Diagnosis
    Role of imaging techniques such as ultrasound, MRI, and lymphoscintigraphy in the assessment of lipedema and its differentiation from other adipose disorders.
  • Laboratory and Clinical Investigations
    Emerging biomarkers and laboratory assessments for lipedema, along with clinical parameters for disease progression monitoring.

  • Conservative Treatment
    Evidence-based non-surgical management approaches, including physical therapy, manual lymphatic drainage, compression therapy, and pharmacological interventions.

  • Nutritional Aspects in Lipedema
    Role of diet and lifestyle modifications in managing lipedema symptoms, with a focus on anti-inflammatory and metabolic interventions.

  • Surgical Treatment
    Advances in surgical techniques such as liposuction and excisional procedures for lipedema, including patient selection criteria and long-term outcomes.

  • Lipedema and the Lymphatic System
    Interaction between lipedema and lymphatic dysfunction, exploring potential links to lymphedema and chronic fluid imbalance.

  • Lipedema and the Venous System
    Investigation of venous insufficiency in lipedema patients, including its contribution to disease progression and therapeutic implications.

  • Ongoing Research Strands
    Latest research developments in lipedema, encompassing genetic studies, novel biomarkers, and innovative treatment modalities.

  • Role of Patient Associations in Favor of Lipedema
    The impact of patient advocacy groups in raising awareness, promoting early diagnosis, influencing healthcare policies, and supporting research initiatives.

CONGRESS PRESIDENTS / meet with us

Karen L. Herbst, MD, PhD

Congress President Los Angeles, United States

    Sandro Michelini, MD, PhD

    Congress President Roma, Italy

    Mojtaba Ghods, MD, PhD

    Congress President Potsdam, Germany

      See all speakers
      @ 2025 LIPEDEMA WORLD CONGRESS